This inventor holds 1 USPTO granted patent. Top assignee: Kanegafuchi Kagaku Kogyo Kabushiki Kaisha. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: The Innovations of Kazunoro Hosoe: A Pioneer in Hydroxystyrene Compounds
Introduction: Kazunoro Hosoe is an accomplished inventor based in Takasago, Japan. With a focus on hydroxystyrene derivatives, he has made significant contributions to the pharmaceutical field. His innovative work addresses diverse medical applications, showcasing the potential of these compounds.
Latest Patents: Kazunoro Hosoe holds a patent for hydroxystyrene compounds recognized for their pharmaceutical utility. This patent details a hydroxystyrene derivative characterized by a complex chemical structure, which includes various groups such as phenyl, benzyl, and others. These derivatives play an essential role in developing antiallergic agents, antibacterial agents, and inhibitors for enzymes like 5-lipoxygenase and tyrosine kinase.
Career Highlights: Hosoe is currently associated with Kanegafuchi Kagaku Kogyo Kabushiki Kaisha, a company known for its commitment to chemical innovation and research. His work has led to advancements in the production of active ingredients used in various therapeutic applications, enhancing the scope of pharmaceutical research.
Collaborations: Throughout his career, Kazunoro Hosoe has collaborated with esteemed colleagues, including Tadayoshi Shiraishi and Keiji Kameyama. Their collective efforts have significantly contributed to the research and development of hydroxystyrene compounds, facilitating considerable progress in the industry.
Conclusion: Kazunoro Hosoe's contributions to the field of pharmaceuticals through his patented hydroxystyrene compounds demonstrate the critical role of inventors in advancing medical science. His collaboration with skilled professionals further enhances the potential for innovative solutions to healthcare challenges, marking him as a significant figure in contemporary therapeutic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
